Skip to main content
. 2018 Apr 19;36(17):2371–2377. doi: 10.1016/j.vaccine.2018.02.021

Table 3.

Vaccine effectiveness (VE) against incident zoster by sex, vaccination cohort, history of zoster and time since vaccination.

Factor Vaccine effectiveness against incident zoster
Level Vaccinated cases/Pyearsa (rate)b Unvaccinated cases/Pyearsa (rate)b VE (95% CI)c pinteractiond
By vaccination cohort Routine 230/77,319 (2.97) 4521/540,007 (8.37) 62% (56%, 67%)
Catch-up 205/60,649 (3.38) 3485/369,467 (9.43) 64% (58%, 69%) 0.58e
By sex Male 161/64,925 (2.48) 3271/424,381 (7.71) 66% (60%, 71%)
Female 274/73,044 (3.75) 4735/485,093 (9.76) 60% (54%, 64%) 0.08e
By history of zoster No history 365/123,185 (2.96) 7145/821,116 (8.70) 64% (60%, 68%)
History 70/14,784 (4.73) 861/88,358 (9.74) 47% (31%, 58%) 0.009e
Time since vaccination <=1 year 197/75,707 (2.60) 69% (65%, 74%)
1–2 years 178/47,954 (3.71) 8006/909,474 (8.80) 54% (47%, 61%)
2–3 years 60/14,307 (4.19) 45% (29%, 57%) <0.001f
Time since vaccination by cohort Routine
<=1 year 95/41,602 (2.28) 71% (65%, 76%)
1–2 years 103/26,640 (3.87) 4521/540,007 (8.37) 49% (38%, 58%)
2–3 years 32/9077 (3.53) 52% (32%, 67%) 0.0002f
Catch-up
<=1 year 102/34,105 (3.00) 69% (62%, 74%)
1–2 years 75/21,313 (3.52) 3485/369,467 (9.43) 61% (50%, 69%)
2–3 years 28/5230 (5.35) 38% (9%, 58%) 0.01f
a

Excludes person-time in the 42 days after vaccination.

b

Rate/1000 person-years.

c

Adjusted for age in years, month and year of study.

d

p value for interaction.

e

Calculated using Wald test for interaction.

f

Calculated using likelihood ratio test.